Ligand binding and hydration in protein misfolding: Insights from studies of prion and p53 tumor suppressor proteins

Accounts of Chemical Research

Volumn 43, Issue 2, 2010, Pages 271-279

  Silva, Jerson L ^a   Vieira, Tuane C R G ^a   Gomes, Mariana P B ^a   Ano Bom, Ana Paula ^a   Lima, Luis Mauricio T R ^b   Freitas, Monica S ^a   Ishimaru, Daniella ^a   Cordeiro, Yraima ^b   Foguel, Debora ^a  

^a Instituto de Bioquimica Medica   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NUCLEIC ACID; PROTEIN P53; WATER;

ARTICLE; CHEMISTRY; HUMAN; METABOLISM; PRION; PROTEIN FOLDING;

HUMANS; LIGANDS; NUCLEIC ACIDS; PRIONS; PROTEIN FOLDING; TUMOR SUPPRESSOR PROTEIN P53; WATER;

EID: 77249149930     PISSN: 00014842     EISSN: 15204898     Source Type: Journal    
DOI: 10.1021/ar900179t     Document Type: Article

References (60)

1. Darwin, C. R. On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life, John Murray: London, 1859.
2. Schrödinger, E. What Is Life? Mind and Matter, Cambridge University Press: 1944.
3. Levy, Y.; Onuchic, J. N. Water Mediation in Protein Folding and Molecular Recognition. Annu. Rev. Biophys. Biomol. Struct 2006, 35, 389-415. (Pubitemid 43877384)
4. Chiti, F.; Dobson, C. M. Protein Misfolding, Functional Amyloid, and Human Disease. Annu. Rev. Biochem. 2006, 75, 333-366.
5. Foguel, D.; Silva, J. L. New Insights into the Mechanisms of Protein Misfolding and Aggregation in Amyloidogenic Diseases Derived From Pressure Studies. Biochemistry 2004, 43, 11361-11370.
6. Balch, W. E.; Morimoto, R. I.; Dillin, A.; Kelly, J. W. Adapting Proteostasis for Disease Intervention. Science 2008, 319, 916-919.
7. Nelson, R.; Sawaya, M. R.; Balbirnie, M.; Madsen, A. O.; Riekel, C.; Grothe, R.; Eisenberg, D. Structure of the Cross-Beta Spine of Amyloid-Like Fibrils. Nature 2005, 435, 773-778. (Pubitemid 40839722)
8. Daidone, L; Ulmschneider, M. B.; Di, N. A.; Amadei, A.; Smith, J. C. Dehydration-Driven Solvent Exposure of Hydrophobic Surfaces As a Driving Force in Peptide Folding. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 15230-15235.
9. Mukherjee, S.; Chowdhury, P.; Gai, F. Effect of Dehydration on the Aggregation Kinetics of Two Amyloid Peptides. J. Phys. Chem. 2009, 113, 531-535.
10. Grudzielanek, S.; Jansen, R.; Winter, R. Solvational Tuning of the Unfolding, Aggregation and Amyloidogenesis of Insulin. J. Mol. Biol. 2005, 351, 879-894. (Pubitemid 41111903)
11. Foguel, D.; Suarez, M. C.; Ferrao-Gonzales, A. D.; Porto, T. C.; Palmieri, L.; Einsiedler, C. M.; Andrade, L R.; Lashuel, H. A.; Lansbury, P. T.; Kelly, J. W.; Silva, J. L. Dissociation of Amyloid Fibrils of Alpha-Synuclein and Transthyretin by Pressure Reveals Their Reversible Nature and the Formation of Water-Excluded Cavities. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 9831-9836.
12. Niraula, T. N.; Konno, T.; Li, H.; Yamada, H.; Akasaka, K.; Tachibana, H. PressureDissociable Reversible Assembly of Intrinsically Denatured Lysozyme Is a Precursor for Amyloid Fibrils. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 4089-4093. (Pubitemid 38405888)
13. Dirix, C.; Meersman, F.; MacPhee, C. E.; Dobson, C. M.; Heremans, K. High Hydrostatic Pressure Dissociates Early Aggregates of TTR105-115, but Not the Mature Amyloid Fibrils. J Mol. Biol. 2005, 347, 903-909. (Pubitemid 40387442)
14. Ferrao-Gonzales, A. D.; Palmieri, L.; Valory, M.; Silva, J. L; Lashuel, H.; Kelly, J. W.; Foguel, D. Hydration and Packing Are Crucial to Amyloidogenesis As Revealed by Pressure Studies on Transthyretin Variants That Either Protect or Worsen Amyloid Disease. J. Mol. Biol. 2003, 328, 963-974.
15. Cordeiro, Y.; Kraineva, J.; Ravindra, R.; Lima, L. M.; Gomes, M. P.; Foguel, D.; Winter, R.; Silva, J. L. Hydration and Packing Effects on Prion Folding and BetaSheet Conversion. High Pressure Spectroscopy and Pressure Perturbation Calorimetry Studies. J Biol. Chem. 2004, 279, 32354-32359.
16. Lee, Y. H.; Chatani, E.; Sasahara, K.; Naiki, H.; Goto, Y. A Comprehensive Model for Packing and Hydration for Amyloid Fibrils of Beta2-Microglobulin. J. Biol. Chem. 2009, 284, 2169-2175.
17. Palhano, F. L.; Leme, L P.; Busnardo, R. G.; Foguel, D. Trapping the Monomer of a Non-Amyloidogenic Variant of Transthyrctin: Exploring Its Possible Use As a Therapeutic Strategy Against Transthyretin Amyloidogenic Diseases. J. Biol. Chem. 2009, 284, 1443-1453.
18. Prusiner, S. BPrions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95,13363-13383.
19. Bueler, H.; Aguzzi, A.; Sailer, A.; Greiner, R. A.; Autenried, P.; Aguet, M.; Weissmann, C. Mice Devoid of PrP Are Resistant to Scrapie. Cell 1993, 73, 1339-1347. (Pubitemid 23201147)
20. Kocisko, D. A.; Come, J. H.; Priola, S. A.; Chesebro, B.; Raymond, G. J.; Lansbury, P. T.; Caughey, B. Cell-Free Formation of Protease-Resistant Prion Protein. Nature 1994, 370, 471-474. (Pubitemid 24263553)
21. Cordeiro, Y.; Machado, F.; Juliano, L; Juliano, M. A.; Brentani, R. R.; Foguel, D.; Silva, J. L. DNA Converts Cellular Prion Protein into the Beta-Sheet Conformation and inhibits Prion Peptide Aggregation. J. Biol. Chem. 2001, 276, 49400-49409. (Pubitemid 37370653)
22. Deleautt, N. R.; Lucassen, R. W.; Supattapone, S. RNA Molecules Stimulate Prion Protein Conversion. Nature 2003, 425, 717-720.
23. Caughey, B.; Baron, G. S. Prions and Their Partners in Crime. Nature 2006, 443, 803-810.
24. De Simone, A.; Dodson, G. G.; Verma, C. S.; Zagari, A.; Fratemali, F. Prion and Water: Tight and Dynamical Hydration Sites Have a Key Role In Structural Stability. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 7535-7540.
25. Cordeiro, Y.; Kraineva, J.; Gomes, M. P.; Lopes, M. H.; Martins, V. R.; Lima, L. M.; Foguel, D.; Winter, R.; Silva, J. L The Amino-Terminal PrP Domain Is Crucial to Modulate Prion Misfolding and Aggregation. Biophys. J. 2005, 89, 2667-2676. (Pubitemid 41401056)
26. Silva, J. L; Lima, L M.; Foguel, D.; Cordeiro, Y. Intriguing Nucleic-Acid-Binding Features of Mammalian Prion Protein. Trends Biochem. Sci. 2008, 33, 132-140.
27. Nandi, P. K.; Leclerc, E. Polymerization of Murine Recombinant Prion Protein in Nucleic Acid Solution. Arch. Virol. 1999, 144, 1751-1763. (Pubitemid 29490035)
28. Lima, L. M.; Cordeiro, Y.; Tinoco, L. W.; Marques, A. F.; Oliveira, C. L.; Sampath, S.; Kodali, R.; Choi, G.; Foguel, D.; Torriani, I.; Caughey, B.; Silva, J. L Structural Insights into the Interaction Between Prion Protein and Nucleic Acid. Biochemistry 2006, 45, 9180-9187. (Pubitemid 44156381)
29. Weiss, S.; Proske, D.; Neumann, M.; Groschup, M. H.; Kretzschmar, H. A.; Famulok, M.; Winnacker, E. L. RNA Aptamers Specifically Interact With the Prion Protein PrP. J. Virol 1997, 71, 8790-8797.
30. Adler, V.; Zeiler, B.; Kryukov, V.; Kascsak, R.; Rubenstein, R.; Grossman, A. Small, Highly Structured RNAs Participate in the Conversion of Human Recombinant PrP(Sen) to PrP(ReS) in Vitro. J Mol. Biol. 2003, 332, 47-51.
31. Gomes, M. P.; Millen, T. A.; Ferreira, P. S.; Silva, N. L.; Vieira, T. C.; Almeida, M. S.; Silva, J. L.; Cordeiro, Y. Prion Protein Complexed to N2a Cellular RNAs Through Its N-Termlnal Domain Forms Aggregates and Is Toxic to Murine Neuroblastoma Cells. J. Biol. Chem. 2008, 283, 19616-19625.
32. Deleautt, N. R.; Harris, B. T.; Rees, J. R.; Supattapone, S. Formation of Native Prions From Minimal Components in Vitro. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 9741-9746.
33. Gabus, C.; Derrington, E.; Leblanc, P.; Chnalderman, J.; Dormont, D.; Swietnicki, W.; Morillas, M.; Surewicz, W. K.; Marc, D.; Nandi, P.; Darlix, J. L. The Prion Protein Has RNA Binding and Chaperoning Properties Characteristic of Nucleocapsid Protein NCP7 of HIV-1. J. Biol. Chem. 2001, 276, 19301-19309. (Pubitemid 37411264)
34. Beaudoin, S.; Vanderperre, B.; Grenier, C.; Tremblay, L; Leduc, F.; Roncou, X. A Large Ribonucleoprotein Particle Induced by Cytoplasmic PrP Shares Striking Similarities With the Chromatoid Body, an RNA Granule Predicted to Function in Posttranscriptional Gene Regulation. Biochim. Biophys. Acta 2007, 1793, 335-345.
35. Yin, S.; Fan, X.; Yu, S.; Li, C.; Sy, M. S. Binding of Recombinant but Not Endogenous Prion Protein to DNA Causes DNA Internalization and Expression in Mammalian Cells. J. Biol. Chem. 2008, 283, 25446-25454.
36. Snow, A. D.; Kisilevsky, R.; Willmer, J.; Prusiner, S. B.; DeArmond, S. J. Sulfated Glycosaminoglycans in Amyloid Plaques of Prion Diseases. Acta Neuropathol. 1989, 77, 337-342.
37. Pan, T.; Wong, B. S.; Liu, T.; Li, R.; Petersen, R. B.; Sy, M. S. Cell-Surface Prion Protein Interacts With Glycosaminoglycans. Biochem. J. 2002, 368, 81-90.
38. Caughey, B.; Brown, K.; Raymond, G. J.; Katzenstein, G. E.; Thresher, W. Binding of the Protease-Sensitive Form of PrP (Prion Protein) to Sulfated Glycosaminoglycan and Congo Red. J. Virol. 1994, 68, 2135-2141. (Pubitemid 24091890)
39. Perez, M.; Wandosell, F.; Colaco, C.; Avila, J. Sulphated Glycosaminoglycans Prevent the Neurotoxicity of a Human Prion Protein Fragment. Biochem. J. 1998, 335, 369-374. (Pubitemid 28491072)
40. Ben-Zaken, O.; Tzaban, S.; Tal, Y.; Horonchik, L.; Esko, J. D.; Vlodavsky, I.; Taraboulos, A. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 2003, 278, 40041-44009 (Pubitemid 37248570)
41. Kocisko, D. A.; Vaillant, A.; Lee, K. S.; Arnold, K. M.; Bertholet, N.; Race, R. E.; Olsen, E. A.; Juteau, J. M.; Caughey, B. Potent Antiscraple Activities of Degenerate Phosphorothioate Oligonucleotides. Antimicrob. Agents Chemother. 2006, 50, 1034-1044. (Pubitemid 43327809)
42. King, D. J.; Safar, J. G.; Legname, G.; Prusiner, S. B. Thioaptamer Interactions With Prion Proteins: Sequence-Specific and Non-Specific Binding Sites. J. Mol. Biol. 2007, 369, 1001-1014.
43. Kimberlin, R. H.; Walker, C. A. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob. Agents Chemother. 1986, 30, 409-413.
44. Vousden, K. H.; Lane, D. P. P53 in Health and Disease. Nat. Rev. Mol. Cell Biol. 2007, 8, 275-283.
45. Joerger, A. C.; Fersht, A. R. Structural Biology of the Tumor Suppressor P53. Annu. Rev. Biochem. 2008, 77, 557-582.
46. Milnor, J.; Medcaff, E. A. Cotranslation of Activated Mutant P53 With Wild Type Drives the Wild-Type P53 Protein into the Mutant Conformation. CEll 1991, 65, 765-774.
47. Butler, J. S.; Loh, S. N. Kinetic Partitioning During Folding of the P53 DNA Binding Domain. J. Mol. Biol. 2005, 350, 906-918. (Pubitemid 40943450)
48. Bullock, A. N.; Henckel, J.; DeDecker, B. S.; Johnson, C. M.; Nikolova, P. V.; Proctor, M. R.; Lane, D. P.; Fersht, A. R. Thermodynamic Stability of Wild-Type and Mutant P53 Core Domain. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14338-14342.
49. Ishimaru, D.; Andrade, L R.; Teixeira, L S.; Quesado, P. A.; Maiolino, L M.; Lopez, P. M.; Cordeiro, Y.; Costa, L T.; Heckl, W. M.; Weissmuller, G.; Foguel, D.; Silva, J. L Fibrillar Aggregates of the Tumor Suppressor P53 Core Domain. Biochemistry 2003, 42, 9022-9027. (Pubitemid 36935410)
50. Ishimaru, D.; Maia, L. F.; Maiolino, L. M.; Quesado, P. A.; Lopez, P. C.; Almeida, F. C.; Valente, A. P.; Silva, J. L. Conversion of Wild-Type P53 Core Domain into a Conformation That Mimics a Hot-Spot Mutant. J. Mol. Biol. 2003, 333, 443-451.
51. Ishimaru, D.; Ano Born, A.P.D.; Lima, L.M.T.R.; Quesado, P. A.; Oyama, M. F. C.; Moura Gallo, C. V.; Cordeiro, Y.; Silva, J. L. Cognate DNA Stabilizes the Tumor Suppressor p53 and Prevents Misfolding and Aggregation. Biochemistry 2009, 48, 6126-6135.
52. Lee, A. S.; Galea, C.; DiGiammarino, E. L.; Jun, B.; Murti, G.; Ribeiro, R. C.; Zambetti, G.; Schultz, C. P.; Kriwacki, R. W. Reversible Amyloid Formation by the P53 Tetramerization Domain and a Cancer-Associated Mutant. J. Mol. Biol. 2003, 327, 699-709.
53. Higashimoto, Y.; Asanomi, Y.; Takakusagi, S.; Lewis, M. S.; Uosaki, K.; Durell, S. R.; Anderson, C. W.; Appella, E.; Sakaguchi, K. Unfolding, Aggregation, and Amyloid Formation by the Tetramerization Domain From Mutant P53 Associated With Lung Cancer. Biochemistry 2006, 45, 1608-1619.
54. Rigacci, S.; Bucciantini, M.; Rolini, A.; Pesce, A.; Gliozzi, A.; Berti, A.; Stefani, M. The (1-63) Region of the P53 Transactivation Domain Aggregates in Vitro into Cytotoxic Amyloid Assemblies. Biophys. J. 2008, 94, 3635-3646.
55. Ishimaru, D.; Lima, L. M.; Maia, L F.; Lopez, P. M.; Ano Bom, A. P.; Valente, A. P.; Silva, J. L. Reversible Aggregation Plays a Crucial Role on the Folding Landscape of P53 Core Domain. Biophys. J. 2004, 87, 2691-2700.
56. Moll, U. M.; Ostermeyer, A G.; Haladay, R.; Winkfield, B.; Frazier, M.; Zambetti, G. Cytoplasmic Sequestration of Wild-Type P53 Protein Impairs the G1 Checkpoint After DNA Damage. Mol. Cell. Biol. 1996, 16, 1126-1137. (Pubitemid 26061684)
57. Giraldo, R. Defined DNA Sequences Promote the Assembly of a Bacterial Protein into Distinct Amyloid Nanostructures. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 17388-17393.
58. Cherny, D.; Hoyer, W.; Subramaniam, V.; Jovin, T. M. Double-Stranded DNA Stimulates the Fibrillation of Alpha-Synuclein in Vitro and is Associated With the Mature Fibrils: an Electron Microscopy Study. J. Mol. Biol. 2004, 344, 929-938.
59. Hegde, M. L; Rao, K. S. DNA Induces Folding In Alpha-Synuclein: Understanding the Mechanism Using Chaperone Property of Osmolytes. Arch. Biochem. Biophys. 2007, 464, 57-69.
60. Weber, G. Protein Interactions, Chapman and Hall: 1992.